Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
TRESIBA FLEXTOUCH U-200 INSULIN 200 UNIT/ML (3 ML) SUBCUTANEOUS PEN (CDM 181954) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 1, 2026 , from http://ppman.hank.ai/transparency/procedure/181954/by-state?code_type=CDM
“TRESIBA FLEXTOUCH U-200 INSULIN 200 UNIT/ML (3 ML) SUBCUTANEOUS PEN (CDM 181954) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/181954/by-state?code_type=CDM. Accessed
July 1, 2026 .
“TRESIBA FLEXTOUCH U-200 INSULIN 200 UNIT/ML (3 ML) SUBCUTANEOUS PEN (CDM 181954) by State,” HANK Price Transparency ,
accessed July 1, 2026 ,
http://ppman.hank.ai/transparency/procedure/181954/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
181954 — Tresiba Flextouch U-200 Insulin 200 Unit/ml (3 Ml) Subcutaneous Pen
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$27,278
National median
$26,991 – $27,565
IQR (p25 – p75)
1
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$101
vs. negotiated
-99.6%
Hospitals reporting
10
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 181954 (CDM), with interquartile range
State Median p25 p75
NE $27,278 $26,991 $27,565